Also trades as: C6O.DE (XETRA) · $vol 0M
CLVS NASDAQ
Clovis Oncology, Inc.
1W: -39.0%
1M: -76.7%
3M: -93.0%
1Y: -97.5%
3Y: -99.3%
5Y: -99.9%
$0.08
Last traded 2022-12-20 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$104M
Revenue
-33.6% YoY
$-252M
Net Income
+15.8% YoY
$-176M
Free Cash Flow
+16.8% YoY
-441.0%
Gross Margin
-3433.8%
Op. Margin
-4170.8%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE78.3%
ROA-58.9%
ROIC971.0%
Valuation
P/E-0.0
P/B-0.0
EV/EBITDA-1.8
Leverage
Debt/Equity-1.10
Current Ratio0.14
Interest Cov.-2.9x
Quality Scores
Piotroski F1/9
Altman Z-15.16
Beneish M9.26